On July 31, medical artificial intelligence (AI) company Lunit announced plans to develop a personalized AI-based integrated ...

Blepharitis, a chronic condition that causes inflammation of the eyelids, affects millions of people across the United States ...

Q2 2025 Management View Kevin Sayer, CEO, announced "second quarter organic revenue growth of 15% compared to the second quarter of 2024," attributing strong performance to "focused execution by our ...

Orr Inbar, CEO and co-founder of QuantHealth, unpacks the growing frustration over drug prices and the misperceptions fueling distrust in the pharmaceutical industry. With clinical trials now more ...

WASHINGTON (AP) — The Trump administration is pushing an initiative for millions of Americans to upload personal health data ...

The latest recalls and health alerts underscore the persistent risks in the U.S. food supply related to allergen mislabeling and other hazards.

Reduce development timelines and costs, while improving access to life-saving treatments VANCOUVER, BC / ACCESS Newswire / July 30, 2025 / Onco-Innovations Limited (CBOE CA:ONCO)(OTCQB:ONNVF)(Frankfur ...

Cardiosense has received U.S. Food & Drug Administration clearance for a wearable sensor that can measure multiple cardiac ...

Among 24 such systems (called devices in FDA parlance) authorized since 2015, FDA summaries for 14 lacked data on the ...

The wearable, noninvasive CardioTag is designed to capture electrocardiogram, photoplethysmogram, and seismocardiogram signals, as well as heart rate and pulse rate.

According to CVS, the recalls aim to "stop the sale of the item and remove it from distribution." Customers who purchased ...

PainChek, EMVision and Clever Culture Systems are among ASX health companies reporting quarterly results today.